Home › Funds › Boston Partners › THC

Boston Partners position in THC

TENET HEALTHCARE CORP · Health Care

Boston Partners reported holding 4,064,662 shares of THC (TENET HEALTHCARE CORP) in its Q3 2026 13F filing — a position valued at US$1.04B, representing 0.93% of its reported portfolio and ranking #21 among its reported holdings. Boston Partners has disclosed THC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)4.06M sh
Reported value held$1.04B
Portfolio Weight0.93%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Boston Partners's THC position evolved

Boston Partners first disclosed a stake in THC in Q3 2023 at 5,761 shares (US$380K). The position peaked in Q3 2026 at 4,064,662 shares, worth US$1.04B. Across 13 filings, Boston Partners increased the stake 9 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 4,064,662 shares valued at US$1.04B — a reduction of -368,698 shares quarter over quarter.. Notable position changes include a 527% increase in Q4 2023 (shares rose 39% over the following quarter), a 230% increase in Q1 2024 (shares rose 27% over the following quarter), a 693% increase in Q1 2025 (shares rose 31% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.76K $379.59K New
Q4 2023 36.12K $2.73M Add
Q1 2024 119.35K $12.53M Add
Q2 2024 154.54K $20.56M Add
Q3 2024 154.32K $25.64M Hold
Q4 2024 146.63K $18.52M Reduce
Q1 2025 1.16M $156.32M Add
Q2 2025 2.27M $398.95M Add
Q3 2025 3.15M $638.96M Add
Q4 2025 3.64M $723.80M Add
Q1 2026 3.83M $723.65M Add
Q2 2026 4.43M $829.06M Add
Q3 2026 4.06M $1.04B Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About THC and 13F data

THC (TENET HEALTHCARE CORP) is a Health Care company. 35 other funds we track also report a position in THC — the largest reported positions include GLENVIEW CAPITAL MANAGEMENT, LLC (US$418.2M), MANNING & NAPIER ADVISORS LLC (US$153.8M), EMINENCE CAPITAL, LP (US$149.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding THC

All THC fund holders →

FAQ

How long has Boston Partners held THC?

Boston Partners has disclosed THC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Boston Partners's current position in THC?

As of Q3 2026, Boston Partners holds 4.06M shares of THC (TENET HEALTHCARE CORP), valued at $1.04B, representing 0.93% of its reported portfolio and ranking #21.

Has Boston Partners been buying or selling THC?

In the latest 13F filing (Q3 2026), Boston Partners reduced its position in THC. The position peaked in Q3 2026 at 4.06M shares.

Which other funds hold THC?

Other major institutional holders of THC include GLENVIEW CAPITAL MANAGEMENT, LLC, MANNING & NAPIER ADVISORS LLC, EMINENCE CAPITAL, LP, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.